MSB 7.69% $1.19 mesoblast limited

Ann: Remestemcel-L for COVID-19 MIS-C published in Pediatrics, page-173

  1. 16,651 Posts.
    lightbulb Created with Sketch. 2375
    Fortunately an employee of Mesoblast and a consultant to Mesoblast were in the vicinity and manged to procure some...
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.